Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation

  • Guix Ràfols, Francesc Xavier
  • Ill-Raga, Gerard, 1982-
  • Bravo, Ramona
  • Nakaya, Tadashi
  • De Fabritiis, Gianni
  • Coma Camprodón, Mireia
  • Miscione, Gian Pietro
  • Villà i Freixa, Jordi
  • Suzuki, Toshiharu
  • Fernàndez Busquets, Xavier
  • Valverde, M. A. (Miguel Ángel), 1963-
  • De Strooper, Bart
  • Muñoz López, Francisco José, 1964-
Alzheimer's disease neuropathology is characterized by neuronal death, amyloid beta-peptide deposits and neurofibrillary tangles composed of paired helical filaments of tau protein. Although crucial for our understanding of the pathogenesis of Alzheimer's disease, the molecular mechanisms linking amyloid beta-peptide and paired helical filaments remain unknown. Here, we show that amyloid beta-peptide-induced nitro-oxidative damage promotes the nitrotyrosination of the glycolytic enzyme triosephosphate isomerase in human neuroblastoma cells. Consequently, nitro-triosephosphate isomerase was found to be present in brain slides from double transgenic mice overexpressing human amyloid precursor protein and presenilin 1, and in Alzheimer's disease patients. Higher levels of nitro-triosephosphate isomerase (P < 0.05) were detected, by Western blot, in immunoprecipitates from hippocampus (9 individuals) and frontal cortex (13 individuals) of Alzheimer's disease patients, compared with healthy subjects (4 and 9 individuals, respectively). Triosephosphate isomerase nitrotyrosination decreases the glycolytic flow. Moreover, during its isomerase activity, it triggers the production of the highly neurotoxic methylglyoxal (n = 4; P < 0.05). The bioinformatics simulation of the nitration of tyrosines 164 and 208, close to the catalytic centre, fits with a reduced isomerase activity. Human embryonic kidney (HEK) cells overexpressing double mutant triosephosphate isomerase (Tyr164 and 208 by Phe164 and 208) showed high methylglyoxal production. This finding correlates with the widespread glycation immunostaining in Alzheimer's disease cortex and hippocampus from double transgenic mice overexpressing amyloid precursor protein and presenilin 1. Furthermore, nitro-triosephosphate isomerase formed large beta-sheet aggregates in vitro and in vivo, as demonstrated by turbidometric analysis and electron microscopy. Transmission electron microscopy (TEM) and atomic force microscopy studies have demonstrated that nitro-triosephosphate isomerase binds tau monomers and induces tau aggregation to form paired helical filaments, the characteristic intracellular hallmark of Alzheimer's disease brains. Our results link oxidative stress, the main etiopathogenic mechanism in sporadic Alzheimer's disease, via the production of peroxynitrite and nitrotyrosination of triosephosphate isomerase, to amyloid beta-peptide-induced toxicity and tau pathology., Spanish Ministerio de Sanidad (FIS: PRO1208; Red HERACLES RD06/0009/002); Educación y Ciencia (BIO2005-01591, SAF2006-4973, CSD2006-00012); Generalitat de Catalunya (GSR2005-266; 2005-SGR00037); EC funded STREP project QosCosGrid (IST-033883); VPH NOE (ICT-223920); Methusalem grant of the Flemish government (to lab of BDS); VIB and KUL (to lab of BDS).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation

  • Guix Ràfols, Francesc Xavier
  • Ill-Raga, Gerard, 1982-
  • Bravo, Ramona
  • Nakaya, Tadashi
  • De Fabritiis, Gianni
  • Coma Camprodón, Mireia
  • Miscione, Gian Pietro
  • Villà i Freixa, Jordi
  • Suzuki, Toshiharu
  • Fernàndez Busquets, Xavier
  • Valverde, M. A. (Miguel Ángel), 1963-
  • De Strooper, Bart
  • Muñoz López, Francisco José, 1964-
Alzheimer's disease neuropathology is characterized by neuronal death, amyloid beta-peptide deposits and neurofibrillary tangles composed of paired helical filaments of tau protein. Although crucial for our understanding of the pathogenesis of Alzheimer's disease, the molecular mechanisms linking amyloid beta-peptide and paired helical filaments remain unknown. Here, we show that amyloid beta-peptide-induced nitro-oxidative damage promotes the nitrotyrosination of the glycolytic enzyme triosephosphate isomerase in human neuroblastoma cells. Consequently, nitro-triosephosphate isomerase was found to be present in brain slides from double transgenic mice overexpressing human amyloid precursor protein and presenilin 1, and in Alzheimer's disease patients. Higher levels of nitro-triosephosphate isomerase (P < 0.05) were detected, by Western blot, in immunoprecipitates from hippocampus (9 individuals) and frontal cortex (13 individuals) of Alzheimer's disease patients, compared with healthy subjects (4 and 9 individuals, respectively). Triosephosphate isomerase nitrotyrosination decreases the glycolytic flow. Moreover, during its isomerase activity, it triggers the production of the highly neurotoxic methylglyoxal (n = 4; P < 0.05). The bioinformatics simulation of the nitration of tyrosines 164 and 208, close to the catalytic centre, fits with a reduced isomerase activity. Human embryonic kidney (HEK) cells overexpressing double mutant triosephosphate isomerase (Tyr164 and 208 by Phe164 and 208) showed high methylglyoxal production. This finding correlates with the widespread glycation immunostaining in Alzheimer's disease cortex and hippocampus from double transgenic mice overexpressing amyloid precursor protein and presenilin 1. Furthermore, nitro-triosephosphate isomerase formed large beta-sheet aggregates in vitro and in vivo, as demonstrated by turbidometric analysis and electron microscopy. Transmission electron microscopy (TEM) and atomic force microscopy studies have demonstrated that nitro-triosephosphate isomerase binds tau monomers and induces tau aggregation to form paired helical filaments, the characteristic intracellular hallmark of Alzheimer's disease brains. Our results link oxidative stress, the main etiopathogenic mechanism in sporadic Alzheimer's disease, via the production of peroxynitrite and nitrotyrosination of triosephosphate isomerase, to amyloid beta-peptide-induced toxicity and tau pathology., Spanish Ministerio de Sanidad (FIS: PRO1208; Red HERACLES RD06/0009/002); Educación y Ciencia (BIO2005-01591, SAF2006-4973, CSD2006-00012); Generalitat de Catalunya (GSR2005-266; 2005-SGR00037); EC funded STREP project QosCosGrid (IST-033883); VPH NOE (ICT-223920); Methusalem grant of the Flemish government (to lab of BDS); VIB and KUL (to lab of BDS).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A nucleotide-based drug protects against glutamate- and MPP+ -induced neurotoxicity

  • Gella Concustell, Alejandro
  • Martiáñez Canales, Tània
  • Lamarca Dams, Aloa
  • Gutierrez, Cristina
  • Durany, Nuria
  • Casals i Farré, Núria
The authors acknowledge and thank the following organizations and persons for their comments, scientific contribution and logistic support for this project: J. L. Lorenzo, Medical Department Ferrer, S. A. (Barcelona). Ferrer, S. A. provided an unrestrictive research grant. This work was partially supported by a public research grant from the Ministerio de Ciencia y Tecnología, Spain, (BIO2002-00128 and BIO2005-01591) and a grant from the Generalitat de Catalunya (2005SGR00270)., Nucleo CMP Forte® is a nucleotide-based drug consisting of cytidinemonophosphate, uridinemonophosphate, uridin-ediphosphate and uridinetriphosphate. It has been prescribed for peripheral nervous system disorders, such as lum-bosciatalgia, diabetic or alcoholic polyneuropathy, or trigeminal neuralgia. Its effects on brain pathologies has re-ceived little attention. We examined its neuroprotective effects on cell toxicity induced by glutamate excitotoxicity or by 1-methyl-4-phenyl-pyridinium (MPP+), an in vitro cell model of Parkinson’s disease. We used the human dopaminergic cell line SH-SY5Y and a primary culture of rat cortical cells pre-treated with the drug for 24 hours and then exposed to MPP+ or glutamate at a range of concentrations. Cell viability was measured at different times. Nucleo CMP Forte® pre-treatment significantly increased the rate of cell division in SH-SY5Y cells, as well as the synthesis of triglycerides and phospholipids. More interestingly, drug pre-treatment significantly reduced MPP+- and glutamate-induced cell death in SH-SY5Y cells and in rat cortical cells. These results indicate that the nucleotides included in Nucleo CMP Forte® are promising therapeutic molecules for the prevention of neuronal death in brain caused by focal ischemia, Parkinson’s disease or other neurodegenerative pathologies., info:eu-repo/semantics/acceptedVersion